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Summary Background/Objective: The present study investigated the efficacy of poly-D,L-
lactic acid (PDLLA) and hyaluronic acid (HyA) on implant fixation when coated onto hydroxy-
apatite/beta-tri-calcium phosphate (HA/bTCP) granules.
Methods: The effect was assessed in a clinically relevant in vivo gap model in sheep. Thus, four
titanium implants combined with either allograft (control), pure HA/bTCP, HyA infiltrated HA/
bTCP, or PDLLA reinforced HA/bTCP granules were bilaterally inserted into the trabecular bone
of the distal femurs in eight sheep. The insertion created a 2-mm peri-implant gap. After 12
weeks, histomorphometry and push-out test was used for quantification of newly formed bone
in the gap, bone-implant contact, and implant fixation.
Results: The histomorphometric analysis revealed the presence of newly formed bone in all
groups, though substitute groups showed fragments of nonabsorbed substitute material. A sig-
nificant larger bone volume was found in the allograft group versus the HA/bTCP-PDLLA group
(Zone 1), and in Zone 2 a statistically significantly larger bone volume was found in the allo-
graft compared with the HA/bTCP group. The mechanical properties and the bone-implant
contact revealed no statistically significant differences between the groups.
Conclusion: This study demonstrates that HA/bTCP granules coated with PDLLA and HyA have
similar bone ingrowth and implant fixation as those with allograft, and with mechanical prop-
erties resembling those of allograft in advance, they may be considered as alternative substi-
tute materials for bone formation in sheep.
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Introduction
The number of total joint replacement surgeries is
increasing each year due to an expanding elderly popula-
tion. Additionally, a rise in the number of failure rate
revision surgeries has been explored, mainly explained by
an impaired bone formation around the implants [1].
Damaged bone is often replaced by metal implants,
providing the strength and stiffness required for most load-
bearing bone sites [2,3]. However, insertion of implants
often also demands supplement of either donor bone or
bone substitutes to secure a proper implant fixation [3,4].
To improve the efficacy and functionality of implants,
lots of effort has been put into the development of new
bone substitutes used in combination with those metal al-
loys. An optimal bone substitute has a high biocompati-
bility, promotes early bone formation at the bone-implant
interface, and retains a suitable strength required at the
particular skeletal site [5,6]. All these factors are essential
for long-term implant survival, being of both social and
economic importance.
Bioceramics, such as beta-tricalcium phosphate (bTCP)
and hydroxyapatite (HA), are known to be very compatible
with the human body environment inducing a biological
response similar to bone [7,8]. Due to their osteoconductive
properties, bTCP and HA are often combined, although
their mechanical properties are not entirely comparable to
that of bone [3,4]. Research has shown that the mechanical
performance of HA/bTCP-ceramics can be enhanced by
reinforcement with polymers, e.g., poly-D,L-lactic acid
(PDLLA), poly-glycolic acid, or poly-hydroxy butyrate [3,9].
PDLLA, a long-chained polymer degraded into lactic acid
by the tricarboxylic acid cycle, is ideal due to its biocom-
patibility, strength, and high solubility [9,10]. Recent
investigation has shown that the addition of 10e15% PDLLA
to HA/bTCP scaffolds significantly increases their strength
[11,12]. Additionally, in vivo studies have revealed that HA
substitutes combined with PDLLA induce bone formation
around titanium implants [12e14]. Another polymer with
favourable bone-stimulating properties is hyaluronic acid
(HyA). HyA is a polysaccharide and an important component
of the extracellular matrix exhibiting several beneficial
chemical properties, i.e., therapeutic agent in arthritis
therapy and anti-inflammatory agent in animal models [15].
Further, it promotes osteoblast differentiation, thereby
stimulating bone formation, as shown in rat calvarial-
derived cell cultures [16] and rat cortical bone [17].
Although the infiltration of HA/bTCP scaffolds with HyA
seems not to improve the mechanical properties [11], HyA
shows good osteoconductive properties, therefore still
considered a resilient composite material. Consequently, it
is interesting to evaluate whether HA/bTCP-PDLLA and HA/
bTCP-HyA could positively affect the fixation of titanium
implants in a clinically relevant large animal model.
The aim of the present study was to investigate the ef-
ficacy of HA/bTCP granules reinforced with PDLLA or infil-
trated with HyA on the fixation of titanium implants
bilaterally inserted into a gap model in sheep. We hypoth-
esized that HA/bTCP substitutes added PDLLA and HyA were
able to conduct formation of bone at the bone-implant
interphase promoting an appropriate mechanical fixation.
Materials and methods
Eight female sheep of the Merino/Gotland wool mixed breed
were used. Their mean age was 4 years (range, 3e5 years)
while their mean body weight was 78.0 7.4 kg. The sheep
were housed in outdoor paddocks and were fed hay and
compound feed throughout the experiment. The animals
were housed indoors at the central animal facility 1 week
prior to surgery and 2e3 days postoperation. All institutional
and national guidelines for the care and use of laboratory
animals were followed, and the Danish Animal Experiments
Inspectorate approved the study (number: 2011/561-1959).
Study design
In this study, 32 cylindrical plasma-sprayed titanium alloys
(90% titanium, 6% aluminium, 4% vanadium; Biomet, War-
saw, IN, USA; Figure 1A) were bilaterally implanted into a
gap model, as previously described [18,19]. The implants
were inserted extra-articularly into trabecular bone of the
medial and lateral distal femoral condyles, clearly sepa-
rated to avoid any potential interference between the
implanted substitute materials. The implants were 10 mm
high and had a column diameter of 6 mm. The footplate and
top washer were 10 mm in diameter, giving a circumfer-
ential gap of 2 mm and a volume of 0.5 mL (Figure 1B).
The gaps were subsequently filled with one of the four
materials: allograft (control), pure HA/bTCP, HA/bTCP-HyA,
or HA/bTCP-PDLLA granules. Thus, four different graft ma-
terials were implanted in each sheep, serving as their own
control. To avoid any site-specific differences, implant ma-
terials were alternated between the gaps. Allograft is
considered the gold standard in many orthopaedic proced-
ures, thus reflectinga relevant control group in this study [20].
Graft materials
Allograft
The allograft was prepared from the distal femurs and
proximal tibias of a healthy donor sheep of the same age.
After removal of cartilage and soft tissue, the bone was
milled in a bone mill (Ossano Scandinavia ApS, Stockholm,
Sweden) resulting in 0.5e1.5-mm bone graft particles. The
bone graft was packed in sterile 1.5-mL vials and preserved
at e80C until surgery.
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Scaffold granules
Porous HA/bTCP granules, consisting of 70% HA and 30%
bTCP, were fabricated by the Danish Technological Institute
(Taastrup, Denmark). The granules had a particle size of
500e1400 mm and a porosity of approximately 80%. The
pore size of the composite graft material was 300e700 mm
with an interconnecting pore size of 100e200 mm. HA/bTCP
granules infiltrated with the biopolymer HyA [molecular
weight (MW)Z 650 kDa] provided by Novozymes (Bags-
vaerd, Denmark) represented the second group of graft
materials. The HyA was coated onto the porous HA/bTCP
granules by sterile solvent infiltration based on demineral-
ized water [11]. Briefly, a solution of 3 mL sterile HyA
(0.15% w/w) was mixed with 1.5 mL pure HA/bTCP granules
and dried under vacuum (room temperature) for 12 hours.
The process was repeated until the final concentration of
HyA reached 0.15%. The final porosity was approximately
80% [11]. HA/bTCP granules reinforced with an ultrathin
layer of 10% PDLLA (50% D-PLA, 50% L-PLA, molecular
weightZ 308 kDa) to enhance their mechanical strength
were provided by PHUSIS (Saint Ismier, France). As previ-
ously shown in our lab, they have a porosity of approxi-
mately 70% [11,12].
Surgical procedure
As premedication, the animals received 0.2 mg/kg of
Rompun (xylancin hydrochloride, 20 mg/mL; Bayer Animal
Health GmbH, Leverkusen, Germany). Anaesthesia was
induced with 3 mg/kg of Rapinovent (propofol 10 mg/mL;
Schering-Plough Animal Health, Ballerup, Denmark), while
the surgical procedures were performed under general
anaesthesia (2.0 % isoflurane). Under aseptic conditions,
and after iodine disinfection of the lateral femur, the
periosteal surface was exposed by an incision through the
skin. To prevent any thermal damage of the bone and sur-
rounding tissue, a low-speed drill created a 12-mm deep
cylindrical hole with a circumference of 10 mm. To remove
residual bone particles, the gap was rinsed with saline
before insertion of the implants forming a gap of 2 mm.
Subsequently, the concentric gap was randomly filled with
one of the four graft materials before the top-washer was
tightly placed on the implant. Finally, the wound was su-
tured in three layers. The procedure was repeated for the
medial side as well as the opposite femur. Postoperative
analgesia (0.03 mL/mg buprenorphine, Temgesic; Schering-
Plough, Ballerup, Denmark) and ampicillin (250 mg/mL
ampicillin; Ampivet Vet, Boehringer Ingelheim, Copenha-
gen, Denmark) was administered daily for 3e4 days [12].
After 12 weeks of observation the sheep were euthanized
with an overdose of pentobarbital and both distal femurs
were harvested and divided prior to further processing.
Preparation of specimens
The bone implant specimens were cut orthogonally into two
parts with an Exakt diamond band saw (Exakt Apparatebau,
Norderstedt, Germany). After removal of the top washer, a
bone-implant sample of 3.5 mm was prepared and stored at
e20C until assessment of bone-implant fixation by me-
chanical push-out test. The remaining part of the implant
specimen, 5.5 mm, was prepared for histological and his-
tomorphometrical investigations. Briefly, the specimens
were dehydrated in graded ethanol series (70e99%) at room
temperature, containing 0.4% basic fuchsine, and subse-
quently embedded in methyl methacrylate (Technovit 9100
NEW; Heraeus Klzer GmbH, Wehrheim, Germany). Using the
vertical sectioning method, four sections (approximately
30 mm thick) from each bone specimen (thus 16 sections per
sheep) were cut using a microtome (Medeja, Leiden, The
Netherlands) and counterstained with 2% light green to
visualize mineralized bone [21].
Mechanical testing
Before assessment of the implant failure by a push-out test
performed on an 858 Bionix Material Testing System (hy-
draulic material testing system; MTS Systems Co., Minneap-
olis, MN, USA), the bone implant specimens were thawed at
room temperature for 2 hours (Figure 2B). The diameter of
the gap was 10 mm and the diameter of the test-plate hole
under the specimen was 10 mm, while the piston pushing out
the implant had a diameter of 6 mm (Figure 2A) [12]. The
displacement rate was 5 mm/min. Load versus displacement
data were recorded and used for calculation of the me-
chanical parametersdultimate shear stiffness (MPa), ulti-
mate shear strength (MPa), and failure energy (kJ/cm2)
(Figure 2C).
Figure 1 (A, B) Porous plasma sprayed titanium implants were inserted into the distal femur condyles of eight sheep and the gaps
were filled with one of four testing materials.
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Histology and histomorphometry
We distinguished bone by green/blue surface staining and
the presence of osteocytes. Using polarized light, we were
able to differentiate between mature lamellar bone with
regular parallel alignment of lamellae and immature woven
bone, characterized by their randomly oriented collagen
fibres and round cell lacunae. Fibrous tissue was stained red
and identified by their visible fibril fibres and low cell
density, while remnants of substitutes were detected as
small grey islets easily identified from the other tissues.
To get unbiased estimates of the anisotropic concentric
gaps, four sections from each implant were analysed by
point counting (newCAST; Visiopharm, Hørsholm, Denmark)
based on the vertical sectioning design [22,23] to quantify
the volume of selected tissues: newly formed bone (BV/
TV), bone marrow, fibrous tissue, and remnants of unre-
sorbed HA/bTCP granules according to the American Soci-
ety for Bone and Mineral Research standards [24]. Tissue
volumes were quantified in two predefined zones adjacent
to the titanium implant: Zone 1, situated close to the
implant surface; and Zone 2, next to host bone. Both zones
had a width of approximately 500 mm (Figure 3). Subse-
quently, by linear interception technique, the boneeim-
plant contact (BIC) was estimated for all groups. Generally,
each section was analysed blinded in a random order.
However, a complete blinding of the sections was not
possible due to easy identification of implant materials,
although we were not able to distinguish from the different
types of substitute material.
Statistical analysis
The statistical significance of the differences between the
control and the substitute groups was analysed using
repeated measurements one-way analysis of variance or a
Friedman’s test. Post hoc multiple comparison analysis was
done either by Bonferroni or Dunn’s test. D’Agostino and
Pearson omnibus normality test was used to assess the
normality of the difference between groups. All graphs and
statistical analysis were prepared in GraphPad Prism
version 5 (GraphPad Software, Inc., La Jolla, CA, USA).
Values of p< 0.05 were considered statistically significant.
Results
Observations on animals
All eight sheep were able to walk 3 days after surgery and
completed the observation period of 12 weeks without any
signs of infection or significant weight change.
Mechanical properties
A destructive push-out test assessing the strength of the
bone-implant interface revealed no statistically significant
difference in the shear stiffness, shear strength, or failure
energy between groups (Table 1).
Figure 2 (A) The bone implant interface was investigated by push-out test on a 858 Bionix Material Testing System hydraulic; (B)
assessing the implant failure of bone specimens; (C) generation of load-displacement curves.
Im
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Figure 3 Schematic view of a titanium implant showing the
regions of interest, approximately 500 mm each. Zone 1 is close
to the implant and Zone 2 close to host bone (H). N represents
the newly formed woven bone.
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Histological observations
Existence of newly formed bone in the concentric gaps was
found in all groups, with remnants of substitute material in
the three substitute groups. The remnants were identified
as small grey islets surrounded by new bone, fibrous tissue,
or bone marrow (Figure 4). The identified bone consisted
only of nonlamellar woven bone, and remnants of allograft
were not detected. Further, no signs of infection or fibro-
cartilage were present in any of the groups.
In four bone specimens, represented by two specimens
from the HA/bTCP group, one from the HA/bTCP-PDLLA
group, and one from the HA/bTCP-HyA group, the BIC could
not be evaluated as no tissues were in direct contact with
the implant surface. This could be explained by encapsu-
lation of the implant by fibrous tissue, which may cause a
shrinking during preparation of the sections. Consequently,
the four specimens were excluded from the BIC analysis.
Histomorphometry
Comparison of the BIC between the groups showed no sta-
tistically significant difference (Table 2), while the bone
marrow volume was statistically significant, greater in the
allograft group (22.1 9.6%) compared with all substitute
groups (HA/bTCP: 5.8 8.1%, HA/bTCP-PDLLA: 5.1 4.3%,
HA/bTCP-HyA: 5.0 6.4%).
The allograft group showed a statistically significantly
larger BV/TV in Zone 1 (31.6 13.0 %) compared with the
HA/bTCP-PDLLA group (18.5 10.6%), whereas in Zone 2
the BV/TV was significantly larger for allograft
(37.7 16.0%) in comparison to the HA/bTCP group
(22.2 7.4%; Table 3).
The volume of fibrous tissue was statistically signifi-
cantly larger in both zones comparing allograft (Zone 1:
36.9 19.0%, Zone 2: 29.0 19.7%) and the HA/bTCP group
(Zone 1: 21.5 8.5%, Zone 2: 12.7 4.2%). However, the
bone marrow volume revealed no statistically significant
difference between the groups, and neither there was any
significant difference in the amount of residual substitutes
between the substitute groups (Table 3).
Discussion
The purpose of this study was to investigate whether HA/
bTCP-HyA or HA/bTCP-PDLLA granules could conduct bone
formation for proper implant fixation in a gap model in
sheep. According to the histomorphometric evaluation, the
allograft group showed a larger BV/TV when compared with
the HA/bTCP-PDLLA group (Zone 1). Despite the lowered
bone formation in the HA/bTCP-PDLLA group, no statisti-
cally significant differences in the mechanical properties as
well as the BIC were detected, comparing both HA/bTCP-
PDLLA and HA/bTCP-HyA to the allograft. Consequently,
the data support our hypothesis that HA/bTCP-PDLLA and
HA/bTCP-HyA can conduct an efficient formation of bone
and subsequent implant fixation in sheep, demonstrating
their continued relevance as synthetic bone substitutes.
The histological investigation revealed the formation of
new bone in the gap of all groups. The significantly lower
BV/TV in Zone 1 of the HA/bTCP-PDLLA group compared
with the allograft group could indicate reduced osteo-
conductive properties of PDLLA. This is consistent with
another study conducted in sheep, showing a delayed for-
mation of bone in gaps filled with PDLLA-coated HA/bTCP
substitutes compared with pure substitutes [25]. A lowered
porosity of substitute material due to PDLLA coating could
explain the reduced bone formation, though the porosity is
considered within the limit ensuring optimal bone ingrowth
Table 1 Mechanical shear properties assessed by push-out
test.
Shear
stiffness
(MPa)
Max shear
strength
(MPa)
Failure
energy
(kJ/cm2)
G1: Allograft 4.8 4.1 1.7 2.4 612.7 1078
G2: HA/bTCP 8.2 9.5 2.3 1.9 635.9 484.8
G3: HA/bTCP-HyA 6.6 7.3 2.3 1.7 738.0 562.4
G4: HA/bTCP-PDLLA 6.2 6.0 2.0 2.1 742.1 783.9
RM one-way ANOVA (p) pZ 0.86 pZ 0.31 pZ 0.1
Data are presented as the mean standard deviation.
nZ 8 for all groups.
ANOVAZ analysis of variance; HA/bTCPZ hydroxyapatite/beta-
tri-calcium phosphate; HyAZ hyaluronic acid; PDLLAZ poly-D,L-
lactic acid; RMZ repeated measures.
Figure 4 (A) Histological section representing the allograft group; (B) histological section representing the hydroxyapatite/beta-
tri-calcium phosphate group. The presence of newly formed bone (B), fibrous tissue (F), bone marrow (M), and nonabsorbed
substitutes (S) are marked on the pictures (magnification 10).
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[11,26,27]. However, the use of PDLLA has been associated
with certain concern due to its acidic degradation and hy-
drophobic surface, potentially provoking an inflammatory
response [28,29]. Additionally, some have reported on the
lack of bone ingrowth for scaffolds consisting purely of
PDLLA [14,30]. However, PDLLA has during the past decades
proven to have an excellent biocompatibility without
causing systemic or local reactions and are thus considered
safe for clinical use. Further, the lowered BV/TV found in
the HA/bTCP-PDLLA group was not in reflected in the re-
sults from the push-out test or the BIC assessment showing
no difference compared with allograft.
Regarding the BIC, numerically higher values were
found in the HA/bTCP group compared with the others,
although not statistically significant. However, it should
be taken into consideration that four of the bone speci-
mens (2 from the HA/bTCP-group, 1 from the HA/bTCP-
PDLLA, and 1 from the HA/bTCP-HyA group) were
excluded due to the absence of tissue in direct contact
with the implant interphase. This exclusion may have
influenced the results, but since it was present in all
substitute groups it is considered to be a consequence of
inappropriate section preparation, and not related to the
type of coating.
A high BIC does not necessarily equal a strong implant
fixation, dependent on an appropriate quality of bone and
structures trabeculae. A push-out test is designed to test
the shear mechanical properties of newly formed bone onto
the implant surface, and no statistically significant differ-
ences in the mechanical properties between the groups
were observed. This indicates that HA/bTCP-HyA and HA/
bTCP-PDLLA offer similar shear strength, modulus, and
failure energy on implant fixation to those of allograft. With
mechanical properties and a BIC similar to allograft, PDLLA
reinforced HA/bTCP showed promising results as an alter-
native bone substitute consistent with recent studies,
where PDLLA coated HA improved the implant performance
in sheep [12,14,19] and rabbit [13]. Moreover, HA/bTCP
Table 2 Histomorphometric data of the bone-implant contact in percentage of the total implant surface.
BV/TV
(%)
Fb.V/TV
(%)
Ma.V/TV
(%)
Remnant substitute
(%)
G1: Allograft 13.0 10.7 61.2 17.0 22.1 9.6 d
G2: HA/bTCP 22.0 12.0 69.5 17.4 5.8 8.1 4.1 6.4
G3: HA/bTCP-HyA 10.8 9.3 77.3 8.1 5.1 4.3 2.9 3.1
G4: HA/bTCP-PDLLA 12.6 7.2 73.2 15.9 5.0 6.4 3.6 1.8
RM one-way ANOVA (p) pZ 0.93 pZ 0.73 p< 0.001 pZ 0.93
Diff. between groups d d G1>G2, G3, G4 d
Data are presented as the mean standard deviation.
G1: nZ 8, G2: nZ 6, G3/G4: nZ 7.
ANOVAZ analysis of variance; BV/TVZ bone volume; Diff.Z difference; Fb.V/TVZ fibrous tissue volume; HA/bTCPZ hydroxyapatite/
beta-tri-calcium phosphate; HyAZ hyaluronic acid; Ma.V/TVZ bone marrow volume; PDLLAZ poly-D,L-lactic acid; RMZ repeated
measures.
Table 3 Histomorphometric data showing the percentage of bone volume per tissue volume in Zone 1 and Zone 2.
BV/TV
(%)
Fb.V/TV
(%)
Ma.V/TV
(%)
Remnant substitute
(%)
Zone 1
G1: Allograft 31.6 13.0 36.9 19.0 22.5 16.9 d
G2: HA/bTCP 22.3 6.7 21.5 8.5 16.2 10.7 35.6 13.7
G3: HA/bTCP-HyA 24.5 12.8 25.6 17.5 15.7 17.5 30.8 8.6
G4: HA/bTCP-PDLLA 18.5 10.6 24.3 13.2 15.1 7.4 35.1 13.1
RM one-way ANOVA (p) p< 0.05 p< 0.05 pZ 0.67 pZ 0.67
Diff. between groups G1>G4 G1>G2 d d
Zone 2
G1: Allograft 37.7 16.0 29.0 19.7 27.0 12.8 d
G2: HA/bTCP 22.2 7.4 12.7 4.2 24.9 9.5 35.1 12.8
G3: HA/bTCP-HyA 33.0 12.8 14.0 9.5 18.6 15.0 31.4 15.0
G4: HA/bTCP-PDLLA 24.6 11.8 21.0 12.2 18.2 9.9 30.5 10.9
RM one-way ANOVA (p) p< 0.05 p< 0.05 pZ 0.29 pZ 0.46
Diff. between groups G1>G2 G1>G2 d d
Data are presented as the mean standard deviation.
nZ 8 for all groups.
ANOVAZ analysis of variance; BV/TVZ bone volume; Diff.Z difference; Fb.V/TVZ fibrous tissue volume; HA/bTCPZ hydroxyapatite/
beta-tri-calcium phosphate; HyAZ hyaluronic acid; Ma.V/TVZ bone marrow volume; PDLLAZ poly-D,L-lactic acid; RMZ repeated
measures.
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scaffolds reinforced with 10% PDLLA has been shown to
attain mechanical properties similar to that of human
cancellous bone [11,13].
We decided to investigate the effect of high molecular
weight (MW) HyA, because this form of HyA is reported to
stimulate the formation of bone as well as supporting an
osteogenic differentiation of bone marrow stem cells
[16,31]. Its presence in callus during fracture healing in
rabbits further supports its potential as a bone ingrowth
stimulator [32]. Our results showed that HyA infiltrated HA/
bTCP granules could conduct a bone formation and implant
fixation comparable to that of allograft. This is in consis-
tence with previous studies showing bone ingrowth around
HyA-coated titanium implants in rabbit femurs [33,34].
Other studies have reported increased osteoblastic activity
[16] and more bone formation in rats when applied to bone
wounds [17]. Borsari and coworkers [35] were, neverthe-
less, not able to detect any significant differences in bone
ingrowth between HyA-coated or uncoated titanium im-
plants inserted in young, aged, and ovariectomized sheep,
respectively.
An apparent limitation of the present study is the small
number of animals included, reducing the power of the
study. However, the gaps were systematically filled with
allograft or substitute, and each animal served as their own
control reducing the biological variation among the in-
dividuals. Insertion of the implants into a nonweight-
bearing position and the fact that the load on the skeletal
sites in sheep is different from humans points out another
weakness of the study prohibiting a direct extrapolation to
patients. However, the design enables an investigation of
the selected bone substitutes in a more controlled milieu
avoiding the influence of, for example, synovial fluids.
Overall, HA/bTCP-PDLLA and HA/bTCP-HyA exhibited an
osteoconductive potential correspondent to allograft,
signifying their promising properties as bone graft sub-
stitutes in a large animal model.
Conclusion
This study has demonstrated that HA/bTCP granules rein-
forced with PDLLA or infiltrated with HyA had similar bone
ingrowth and implant fixation as those with allograft.
In perspective, mechanical properties resembling those
of allograft in advance, the bone substitutes may be
considered as alternatives to allograft for bone healing in
this sheep model.
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